Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
• To assess tolerability and safety of topical LFX453 formulations in patients with actinic keratosis (AK) • To assess efficacy of topical LFX453 formulations in treating AK compared to vehicle after 2 cycles of 4 week treatment.
Critère d'inclusion
- Actinic Keratosis